Peptide Pen Mito Boost

Description

Mito Boost delivers 60mg MOTS-c in up to 18 longevity-enhancing, performance-boosting doses.

Prime pen before first use
Dose per injection: 5 mg (standard for athletic performance, recovery, endurance, and mitochondrial optimization studies)
Clicks per dose: 22 clicks (delivers exactly 5 mg based on the pen’s calibration)
Alternative lower dose: 3 mg = 13 clicks (for longevity/maintenance or sensitive research models)
Frequency: 2–3 times per week (e.g., Monday/Wednesday/Friday, or spaced around training modeling for best results)
Timing: Morning or pre-workout to maximize energy, stamina, and recovery parameter studies
Cycle: Typically 4–12 weeks on, followed by 4 weeks off to maintain efficacy and prevent potential tolerance
Optional loading phase (first 2–4 weeks for accelerated results): 5 mg 3×/week, then drop to 2×/week or once weekly for maintenance if desired

Product Name: Mito Boost Pen

Formulation: 2.6 mL pre-filled pen

Clicks per Pen: 240

Total Amount: 60 mg MOTS–C

Supplied with: 6 sterile needles (extras available)

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16–amino–acid mitochondrial–derived peptide (MDP) encoded within the mitochondrial 12S rRNA gene.

Chemical Structure

Sequence: Met-Arg-Trp–Gln–Glu–Met–Gly–Tyr–Ile-Phe-Tyr–Pro–Arg–Lys–Leu-Arg (MRWQEMGYIFYPRKLR)
Molecular weight: ~2,173 Da
It is a linear peptide with no disulfide bonds or post–translational modifications in its native form.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation.
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

MOTS-C is generally well tolerated across preclinical and early human studies. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching
Transient headache or light–headedness
Temporary fatigue or changes in energy levels during initial use
Rare mild gastrointestinal discomfort (nausea, bloating)
If any severe or persistent symptoms occur (e.g., severe headache, abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

All Peptide Pen products are intended for laboratory and research purposes only. They are not approved for human consumption, medical use, or therapeutic application. These products are not intended to diagnose, treat, cure, or prevent any disease. Always handle peptides in accordance with proper laboratory safety and research protocols.